Unaudited Standalone and Consolidated Result for the quarter ended June 30, 2026

August 07, 2026 The Manager The Manager BSE Limited The National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, P. J. Towers, Dalal Street, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 001. Mumbai – 400 051. BSE Scrip Code No. 524280 NSE Symbol : KOPRAN Dear Sir/Madam, Re: Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (“SEBI LODR”) Sub: Outcome of Board Meeting held on August 07, 2026 The Board of Directors of the Company at its Meeting held today inter- alia, as recommended by the Audit Committee, have considered and approved the Statement of Unaudited Standalone and Consolidated Financial Results of the Company for the First Quarter ended on June 30, 2026 along with Limited Review Reports of the Statutory Auditor thereon. Kindly publish the results on your websites. The Board Meeting commenced at HH:MM 10.45 & concluded at HH:MM 12.40 Regards, For Kopran Limited Sunil Sodhani Company Secretary & Compliance Officer Membership No. FCS 3897 Encl : As above KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111 Fax: (022) 2495 0363 Website: www.kopran.com CIN – L 24230 MH 1958 PLC 011078. E-mail: cs@kopran.com Works:• Village Savroli, Taluka: Khalapur, District: Raigad - 410 202. Tel.: (02192) 274500 / 335 / 337•Fax: (02192) 274025 KOPRAN LIMITED STATEMENT OF CONSOLIDATED AND STANDALONE UNAUDITED FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2026 Rs. In Lakhs Particulars Consolidated Standalone For the Quarter ended For the Year For the Quarter ended For the Year ended ended 30/06/2026 31/03/2026 30/06/2025 31/03/2026 30/06/2026 31/03/2026 30/06/2025 31/03/2026 Unaudited Audited Unaudited Audited Unaudited Audited Unaudited Audited ./ll Revenue from Ocerations 15 399.43 23 401.83 13 521.62 68142.36 6 275.79 11803.92 5 133.48 30 564.62 2) Other Income 7.79 9.04 16.18 34.57 32.95 100.34 35.19 199.89 131 Forei1m Exchanlle Gain (Net 197.62 - 239.37 258.39 - 144.56 - 4) Total Income 11+2+31 15 604.84 23 410.87 13 777.17 68176.93 6 567.13 11904.26 5,313.23 30 764.51 (SI Exoenses (al Cost of materials consumed 12 089.08 13 992.94 8 030.23 43118.17 3 754.81 5 827.57 2 736.46 16 287.23 /bl Purchase of stock-in-trade 419.85 183.95 38.87 373.82 427.56 157.59 38.87 347.46 (c) Changes In Inventories of finished goods, stock-in-trade and work-in- (3,392.52) 477.58 471.28 409.56 (1,029.24) 437.36 192.17 378.64 progress (d) Empfovee benefits expense 1846.32 1 645.57 1543.29 6 521.31 882.85 835.71 734.79 3 294.29 /el Finance costs 328.20 317.08 253.78 1047.15 123.84 117.22 104.25 419.96 (f) Depreciation and amortisation expense 577.21 451.58 425.91 1 747.27 134.75 134.44 121.94 498.11 /Ill Other excenses 2.856.41 3 044.53 2 024.90 9 929.46 1394.18 1 748.90 923.99 5 146.91 (h) Forell!n ExchanRe Loss (Netl - 762.75 - 1594.57 138.18 - 352.52 TotalExoenses 51 14.724.55 20 875.98 12 788.26 64 741.31 5 688.75 9 396.97 4 852.47 26 725.12 (6) Profit /(Loss before exceotlonal Items and tax 14-51 880.29 2 534.89 988.91 3 435.62 878.38 2 507.29 460.76 4 039.39 171 Exceotional items /Netl - - - - . - - - 8) Profit /(Loss before tax (6-7) 880.29 2 534.89 988.91 3 435.62 878.38 2 507.29 460.76 4039.39 191 Tax exoense (a) Current Tax 193.25 578.33 222.45 903.61 193.25 578.33 108.01 903.61 /bl Deferred Tax 16.95 70.01 21.53 /41.11) 12.83 54.53 0.94 95.81 (10) Profit /(Loss) for the oeriod/vear (8 -91 670.09 1886.55 744.93 2 573.12 672.30 1 874.43 351.81 3 039.97 1111 Other Comorehensive Income (I) Items that will not be reclassified to orofit and loss (al -Remeasurements of defined benefit clans 10.38 128.66 129.031 41.56 10.37 88.28 115.59' 41.51 Income tax effect on Remeasurement of defined employee benefit (2.62) (32.38) 7.30 {10.47) (2.61) (22.22) 3.92 (10.45) clans (b) -Net changes in Fair value of investments in equity shares carried - - - - - - - at fair value throuRh OCI Income tax effect on Fair value of investments in equity shares - - - . - - - carried at fair value throullh OCI iil al Items that will be reclassified to profit or toss Exchange difference in translating the financial statements of foreign 3.18 8.44 (1.52) 20.76 . - - - ooeration Other Comprehensive Income /(Lossl 1111 10.94 104.72 123.25) 51.85 7.76 66.06 111.671 31.06 11121 Total Comoreh "Loss\ 110+111 681.03 1,991.27 721.68 2 624.97 680.06 1940.49 340.14 3 071.03 2flr..\'t< ~( \J\\ } . ) I ~ 41uiffs. ::::i Particulars Consolidated Standalone For the Quarter ended For the Year For the QuartEr ended For the Year ended ended 30/06/2026 31/03/2026 30/06/2025 31/03/2026 30/06/2026 31/03/2026 30/06/2025 31/03/2026 Unaudited Audited Unaudited Audited Unaudited Audited Unaudited Audited 1013.13 582.70 Profit attributable to -Owners of the Company 670.09 1886.55 744.93 2 573.12 - - - - - - - - - - -Non -Controllinl! Interest Other Comprehensive Income I (Loss) attributable to - - - - -Owners ofthe Comoanv 10.94 104.72 (23.25) 51.85 -Non -Controlling Interest - - - - - - - - Total Comprehensive Income attributable to - - - - -Owners of the Comoanv 681.03 1 991.27 721.68 2 624.97 - - - - - - - - -Non -Controlling Interest 13) Paid uo Ecuitv Share Caoital (Face Value of Rs. 10 eachl 4 828.56 4 828.56 4 828.56 4828.56 4 828.56 4 828.56 4 821.06 4 828.56 (141 Other Eauitv 48 199.49 39 954.54 15) Earnings Per Share CEPS) {Face value Rs. 10/-each) lal Basic 1.39 3.91 1.54 5.33 1.39 3.83 0.73 6.30 (bl Diluted 1.39 3.91 1.54 5.33 1.39 3.8S 0.73 6.30 Notes:- 1) The above Statement of consolidated and standalone unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act 2013, read with Companies (Indian Accounting Standards) Rules, 2015, as amended and other accounting principles generally accepted in India. There is no minority interest. 2) The above Statement of consolidated and standalone unaudited financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 7, 2026 and have been reviewed by the Statutory Auditors of the Company who have expressed unmodified opinion. 3) The Company and the subsidiaries together referred to as "Group" are engaged primarily in the Pharmaceuticals business and there are no separate reportable segments as per Ind AS 108 on " Operating Segment Reporting". 4) Figures for the previous period have been regrouped or reclassified, wherever necessary to make them comparable with the figures of the current period. - .-.-- ~\..,.',..f. t~. .J..4. ..1, ,f, ~;;-r--~N I :~ :( l MU .•~ BAI }(" ~I I . ~. 'O~ ?~ -i I /: ~:; l Place: Mumbai ~ ~ ~LI ~~Somool "'~"' """°' ACC'U IN:OD600860 KHANDELWAL JAIN & CO. - - - - - - - - - - - - - - CHARTERED ACCOUNTANTS 6-B&C, Pil Court, 6th Floor, Tel.: (+91-22) 431 i 5000 l l l, M. Karve Road, Churchgate, E-mail: kjco@kjco.net Mumbai -400 020. Website: www.kjco.net Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of Kopran Limited pursuant to the Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,2015, as amended The Board of Directors of Kopran Limited 1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of Kopran Limited, ("the Company") for the quarter ended June 30, 2026 ("the Statement"), attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors of the Company, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Report [Showing first 8,000 characters — download PDF for full document]